This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998 Nov 4;95(45):4983-4, 4987.

[More active therapy in diabetes type 2 is justified by findings in a break-through study. 20-year follow-up of over 5000 patients]

[Article in Swedish]

P Nilsson¹, S Attvall, M Eliasson

Affiliations

PMID: 9835711

Review

[More active therapy in diabetes type 2 is justified by findings in a break-through study. 20-year follow-up of over 5000 patients]

[Article in Swedish]

P Nilsson et al. Lakartidningen. 1998.

. 1998 Nov 4;95(45):4983-4, 4987.

Authors

P Nilsson¹, S Attvall, M Eliasson

Affiliation

¹ Kliniska forskningsenheten, Universitetssjukhuset MAS, Malmö.

PMID: 9835711

No abstract available

PubMed Disclaimer

Comment in

[Limited effect of antidiabetics on type 2 diabetes].
Lindeberg S. Lindeberg S. Lakartidningen. 1998 Dec 2;95(49):5605-6. Lakartidningen. 1998. PMID: 9863297 Swedish. No abstract available.

Similar articles

Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
Jansson SP, Andersson DK, Svärdsudd K. Jansson SP, et al. Diabet Med. 2013 Mar;30(3):349-57. doi: 10.1111/dme.12106. Diabet Med. 2013. Retraction in: Diabet Med. 2013 Jul;30(7):888. PMID: 23278364 Retracted.
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
[No authors listed] [No authors listed] Diabetes. 1995 Nov;44(11):1249-58. Diabetes. 1995. PMID: 7589820 Clinical Trial.
Long-term cost-effectiveness of insulin detemir versus NPH insulin in type 2 diabetes in Sweden.
Smith-Palmer J, Fajardo-Montañana C, Pollock RF, Ericsson A, Valentine WJ. Smith-Palmer J, et al. J Med Econ. 2012;15(5):977-86. doi: 10.3111/13696998.2012.692340. Epub 2012 May 23. J Med Econ. 2012. PMID: 22563742
Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
Herz M. Herz M. Int J Clin Pract Suppl. 1999 Jul;104:8-13; discussion 18-20. Int J Clin Pract Suppl. 1999. PMID: 12669732 Review. No abstract available.
[Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
Kishikawa H, Araki E, Wake N, Shichiri M. Kishikawa H, et al. Nihon Rinsho. 2002 Sep;60 Suppl 9:140-5. Nihon Rinsho. 2002. PMID: 12386985 Review. Japanese. No abstract available.

See all similar articles

Cited by

Dietary advice for treatment of type 2 diabetes mellitus in adults.
Nield L, Moore HJ, Hooper L, Cruickshank JK, Vyas A, Whittaker V, Summerbell CD. Nield L, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004097. doi: 10.1002/14651858.CD004097.pub4. Cochrane Database Syst Rev. 2007. PMID: 17636747 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information